PAR5 DISEASE SEVERITY AND COSTS AMONG PATIENTS STARTING A TREATMENT WITH COX-2 SPECIFIC INHIBITORS VERSUS NSAIDS PATIENTS IN ITALY- QUANTITATIVE ASSESSMENT IN 442 PATIENTS WITH ARTHRITIS
Nov 1, 2002, 00:00
10.1016/S1098-3015(10)61270-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)61270-3/fulltext
Title :
PAR5 DISEASE SEVERITY AND COSTS AMONG PATIENTS STARTING A TREATMENT WITH COX-2 SPECIFIC INHIBITORS VERSUS NSAIDS PATIENTS IN ITALY- QUANTITATIVE ASSESSMENT IN 442 PATIENTS WITH ARTHRITIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61270-3&doi=10.1016/S1098-3015(10)61270-3
First page :
Section Title :
Open access? :
No
Section Order :
78